The Ohio Board of Pharmacy’s August 11 settlement resolves Pure Health Aesthetics & Wellness’s June 2026 TDDD suspension after the clinic admitted the allegations and agreed to a $25,000 penalty, Responsible Person training, and six hours of pre-approved continuing education.
Pure Health Settlement Resolves Ohio TDDD Summary Suspension
On August 11, 2026, the Ohio Board of Pharmacy reinstated Pure Health Aesthetics & Wellness’s TDDD license under a settlement after the clinic admitted the allegations, including unauthorized use of prescriber credentials, drug sourcing, and medication storage and recordkeeping. For Med Spa and aesthetic operators, the case shows how Ohio pharmacy requirements can apply within a combined Med Spa and chiropractic clinic that purchases, stores, and personally furnishes dangerous drugs under a TDDD license.
Ohio Board of Pharmacy Enforcement Timeline and Settlement Details
An August settlement agreement brings the Pure Health case from its June TDDD license summary suspension to a final administrative resolution. The Ohio Board of Pharmacy initially suspended the clinic’s TDDD license on June 1, 2026, after an investigation identified alleged violations involving prescriber credentials, personally furnishing dangerous drugs, drug sourcing, medication storage and security, and required records.
Under the new settlement, Pure Health admitted the allegations in the June notice, and the Board adjudicated them as violations of Ohio pharmacy law. The prior allegations included unauthorized use of APRN NPI numbers to order NAD and sermorelin, personally furnishing drugs without documented prescriber orders, receipt of purported BPC-157 from an unlicensed source, and violations involving drug storage, security, inventory, and recordkeeping.
Following the June 1 suspension, Pure Health requested an administrative hearing on June 23 and later sought a continuance. Before the rescheduled January 6, 2027 hearing, the parties entered the August 11 settlement, ending the administrative proceeding and establishing reinstatement terms.
The settlement terms include:
- License reinstatement: The Board lifted the summary suspension and reinstated Pure Health’s TDDD license effective August 11.
- Monetary penalty: Pure Health must pay a $25,000 penalty within six months of the settlement’s effective date.
- Required education: The Responsible Person must complete the Board’s one-hour Prescriber Clinics/Med Spas presentation and six hours of pre-approved continuing education in drug storage and handling, regulatory compliance, and/or law and ethics.
- Hearing rights: Pure Health withdrew its hearing request and waived its right to a hearing and appeal.
The agreement also requires Pure Health to comply with applicable state and federal requirements governing TDDD operations and dangerous drugs. The disciplinary action must also be disclosed to the appropriate licensing authorities where required.
DISCOVER YOUR MED SPA’S GROWTH POTENTIAL
How much time and revenue could you unlock by outsourcing your GFEs?
Use our GFE Calculator to find out in under 5 minutes. It’s quick, easy, and tailored to your Med Spa.
Source Attribution
According to the Ohio Board of Pharmacy’s August 11, 2026, Settlement Agreement in Case No. A-2026-0164, Pure Health admitted the allegations contained in the June 1 summary suspension notice, and the Board reinstated the clinic’s TDDD license subject to the agreement’s terms.
Ohio TDDD Compliance Context and Responsible Person Requirements
This case centers on the operational duties attached to an Ohio TDDD license and its designated Responsible Person. Under Ohio Revised Code § 4729.55, a terminal distributor must maintain supervision and control over dangerous drugs and safeguards against unauthorized distribution. Ohio Administrative Code Rule 4729:5-2-01(E)(6) further assigns the Responsible Person responsibility for ensuring requirements involving supervision, safeguards, drug security and control, and required records are met.
The underlying enforcement action addressed several defined areas of TDDD compliance:
- Prescriber authority: Use of prescriber credentials and documented authorization for dangerous drugs.
- Drug sourcing: Purchasing dangerous drugs from appropriately authorized sources and verifying sellers before wholesale purchases.
- Personally furnishing drugs: Prescriber involvement and required documentation when drugs are provided directly to patients.
- Storage and security: Access controls, multidose vial handling, refrigeration monitoring, and security of dangerous drugs.
- Inventory and records: Controlled-substance inventories, purchasing records, Responsible Person changes, and medication documentation.
Ohio TDDD requirements apply to licensed medication operations and the individuals responsible for supervising them.
State-level actions have also addressed prescribing authority and medication operations in aesthetic and wellness settings, including a North Carolina case involving allegations of unlicensed tirzepatide prescribing. In Ohio, the Medical, Pharmacy, and Nursing Boards have separately addressed medication oversight through a joint regulatory statement on IV therapy in Med Spas, including prescriber authority, drug preparation, and administration requirements. For Med Spas operating within broader healthcare businesses, applicable TDDD requirements govern the licensed medication operations and the individuals responsible for supervising and conducting activities involving those drugs.
Practical Implications for Ohio Med Spas and Clinics With TDDD Licenses
- Clarify which clinicians are authorized to order, prescribe, furnish, and administer dangerous drugs within the practice.
- Confirm prescriber credentials are used only with the prescriber’s knowledge and authorization.
- Check active drug stock for opened, expired, returned, or improperly labeled medications.
- Review Responsible Person designations and notify the Board within required timeframes if that role changes.
- Ensure the Responsible Person oversees TDDD supervision, drug security and control, required records, and medication-handling procedures.
What to Watch Next
As of this reporting, the Ohio Board of Pharmacy’s settlement agreement reinstates Pure Health’s TDDD license under the terms of the agreement. Any additional orders, guidance, or licensure updates from the Ohio Board of Pharmacy or other applicable Ohio licensing boards may provide further context for TDDD compliance in Med Spa and clinic settings.
About Spakinect
Spakinect provides compliance infrastructure and telehealth-supported supervision solutions for medical aesthetic practices. For additional information, see our website.
Image Attribution: “Ohio State Office Building 2” by Sixflashphoto, via Wikimedia Commons, licensed under CC BY-SA 4.0.
